Pfizer to Sponsor Large New Celebrex Trial
240625
Pfizer Inc. said on Monday it plans to sponsor a major clinical study to further assess the cardiovascular safety of its arthritis drug Celebrex following the withdrawal of Merck & Co.'s Vioxx, a drug in the same class.
578981
Pfizer Inc. on Monday said a major new  trial will test whether its  popular Celebrex arthritis drug  increases the risk of heart attacks, as seen with Merck and  Co.'s recalled Vioxx pill.
601823
Pfizer does not plan to recall Celebrex, but the company would immediately halt advertising this popular arthritis drug to consumers after a study showed that high doses were
64597
Pfizer Inc. on Friday reported an increased risk of heart problems among patients taking high doses of its popular painkiller and arthritis drug Celebrex.
169285
A study of the arthritis drug Celebrex made more than four years ago by Pfizer Inc. casts doubt on the company's insistence that it had no hint of the drug's potential heart and stroke risks until recently.-The Washington Post
698387
FRIDAY, Dec. 17 (HealthDayNews) -- Pfizer Inc. said Friday that a study of its popular pain drug Celebrex in cancer patients had found an apparent increased risk of heart attack and other cardiovascular problems.
753810
Amid growing concerns, the maker of the widely sold arthritis drug announced Monday that it will soon begin a major clinical trial to determine whether the drug is safe for long-term use.
626406
New prescriptions for Pfizer Inc.&#39;s arthritis drug Celebrex fell 56 percent last week after the company released data showing the drug may increase the risk of heart attacks and strokes, the Wall Street Journal said.
482981
NEW YORK - Pfizer Inc. said it found an increased risk of heart attacks for patients taking high dosages of its top-selling painkiller Celebrex, the same problem that led to the withdrawal of its one-time competitor Vioxx.
268241
The study will involve osteoarthritis patients at high risk for cardiovascular disease, though Pfizer remains confident in the long-term safety of Celebrex.
514348
Pfizer Inc. won U.S. approval on Friday to promote its Celebrex pain reliever for treating children age two and older who have rheumatoid arthritis, the Food and Drug Administration said on Friday.
357920
Pfizer Inc. on Friday said patients  taking its blockbuster arthritis drug Celebrex in a long-term  cancer-prevention trial had more than twice the number of fatal  or non-fatal heart attacks as those taking a placebo.
546632
New prescriptions for Pfizer Inc.'s arthritis drug Celebrex fell 56 percent last week after the company released data showing the drug may increase the risk of heart attacks and strokes, the Wall Street Journal said.
178276
In an announcement that many doctors were waiting for, Pfizer Inc. said its top-selling painkiller Celebrex -- which is similar to Vioxx -- caused an increased risk of heart attacks when used in high doses during a clinical trial.
301330
New prescriptions for Pfizer Inc.&#39;s arthritis drug Celebrex fell 56 percent last week after the company released data showing the drug may increase the risk of heart attacks and strokes, according to Verispan, a market research company
496302
Pfizer Inc.&#39;s bid to head off a Celebrex recall may get a boost from new government data showing the painkiller didn&#39;t raise heart risks in a study, while Aleve, which is sold by Bayer AG, did, investors said.
31944
Pharmaceutical giant Pfizer Inc. will  announce plans for a large-scale clinical trial of the ability  of blockbuster drug Celebrex to prevent heart attacks and  strokes in patients with cardiovascular disease, the Wall  Street Journal reported on Monday.